Regulation of iron acquisition and iron distribution in mammals

被引:182
作者
Ganz, Tomas [1 ]
Nemeth, Elizabeta [1 ]
机构
[1] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med & Pathol, Los Angeles, CA 90095 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2006年 / 1763卷 / 07期
关键词
hepcidin; iron; hemochromatosis; anemia of inflammamtion; iron transport;
D O I
10.1016/j.bbamcr.2006.03.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Both cellular iron deficiency and excess have adverse consequences. To maintain iron homeostasis, complex mechanisms have evolved to regulate cellular and extracellular iron concentrations. Extracellular iron concentrations are controlled by a peptide hormone hepcidin, which inhibits the supply of iron into plasma. Hepcidin acts by binding to and inducing the degradation of the cellular iron exporter, ferroportin, found in sites of major iron flows: duodenal enterocytes involved in iron absorption, macrophages that recycle iron from senescent erythrocytes, and hepatocytes that store iron. Hepcidin synthesis is in turn controlled by iron concentrations, hypoxia, anemia and inflammatory cytokines. The molecular mechanisms that regulate hepcidin production are only beginning to be understood, but its dysregulation is involved in the pathogenesis of a spectrum of iron disorders. Deficiency of hepcidin is the unifying cause of hereditary hemochromatoses, and excessive cytokine-stimulated hepcidin production causes hypoferremia and contributes to anemia of inflammation. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:690 / 699
页数:10
相关论文
共 82 条
[71]   Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis [J].
Roetto, A ;
Papanikolaou, G ;
Politou, M ;
Alberti, F ;
Girelli, D ;
Christakis, J ;
Loukopoulos, D ;
Camaschella, C .
NATURE GENETICS, 2003, 33 (01) :21-22
[72]   DRAGON: A member of the repulsive guidance molecule-related family of neuronal- and muscle-expressed membrane proteins is regulated by DRG11 and has neuronal adhesive properties [J].
Samad, TA ;
Srinivasan, A ;
Karchewski, LA ;
Jeong, SJ ;
Campagna, JA ;
Ji, RR ;
Fabrizio, DA ;
Zhang, Y ;
Lin, HY ;
Bell, E ;
Woolf, CJ .
JOURNAL OF NEUROSCIENCE, 2004, 24 (08) :2027-2036
[73]   Identification of an intestinal heme transporter [J].
Shayeghi, M ;
Latunde-Dada, GO ;
Oakhill, JS ;
Laftah, AH ;
Takeuchi, K ;
Halliday, N ;
Khan, Y ;
Warley, A ;
McCann, FE ;
Hider, RC ;
Frazer, DM ;
Anderson, GJ ;
Vulpe, CD ;
Simpson, RJ ;
McKie, AT .
CELL, 2005, 122 (05) :789-801
[74]  
SKIKNE BS, 1992, J LAB CLIN MED, V120, P746
[75]   Diagnosis and management of hemochromatosis [J].
Tavill, AS .
HEPATOLOGY, 2001, 33 (05) :1321-1328
[76]  
Theil EC, 2003, J NUTR, V133, p1549S, DOI 10.1093/jn/133.5.1549S
[77]   The molecular defect in hypotransferrinemic mice [J].
Trenor, CC ;
Campagna, DR ;
Sellers, VM ;
Andrews, NC ;
Fleming, MD .
BLOOD, 2000, 96 (03) :1113-1118
[78]  
VIATTE L, 2005, BLOOD
[79]   A role of SMAD4 in iron metabolism through the positive regulation of hepicidin expression [J].
Wang, RH ;
Li, CL ;
Xu, XL ;
Zheng, Y ;
Xiao, CY ;
Zerfas, P ;
Cooperman, S ;
Eckhaus, M ;
Rouault, T ;
Mishra, L ;
Deng, CX .
CELL METABOLISM, 2005, 2 (06) :399-409
[80]   Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease [J].
Weinstein, DA ;
Roy, CN ;
Fleming, MD ;
Loda, MF ;
Wolfsdorf, JI ;
Andrews, NC .
BLOOD, 2002, 100 (10) :3776-3781